Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer
Sanghoon Lee(The University of Texas MD Anderson Cancer Center), Anil K. Sood(The University of Texas MD Anderson Cancer Center), Jeremy Loffredo(Inova Health System), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Li Zhao(BGI Group (China)), Nicholas W. Bateman(Inova Health System), Clifton L. Dalgard(Uniformed Services University of the Health Sciences), Jared K. Burks(The University of Texas MD Anderson Cancer Center), Robert L. Coleman(Texas Oncology), G. Larry Maxwell(Inova Health System), Xingzhi Song(The University of Texas MD Anderson Cancer Center), Shannon N. Westin(The University of Texas MD Anderson Cancer Center), Kristin Roman(Akoya Biosciences (United States)), Coralie Viollet(AstraZeneca (United Kingdom)), Gloria L. Fawcett(Center for Personalized Cancer Treatment), Matthew D. Wilkerson(Uniformed Services University of the Health Sciences), Nirad Banskota(National Institutes of Health), Jerez A. Te(Henry M. Jackson Foundation), Randy Chu(The University of Texas MD Anderson Cancer Center), Robert Dood(Huntsman Cancer Institute), Agda Karina Eterovic(Center for Personalized Cancer Treatment), Brian L. Hood(Inova Health System), Ming Zhou(Central South University), Joseph Celestino(The University of Texas MD Anderson Cancer Center), Anthony R. Soltis(Massachusetts Institute of Technology), David Cordover(Akoya Biosciences (United States)), P. Andrew Futreal(Wellcome Sanger Institute), Yovanni Casablanca(Levine Cancer Institute), Karen H. Lu(The University of Texas MD Anderson Cancer Center), Thomas P. Conrads(Inova Health System), Nicole D. Fleming(The University of Texas MD Anderson Cancer Center), Tri Nguyen(The University of Texas MD Anderson Cancer Center), Jianhua Zhang(XinHua Hospital), Jinsong Liu(Guangzhou Institutes of Biomedicine and Health), Hui Yao(The University of Texas MD Anderson Cancer Center), Olivia D. Lara(The University of Texas MD Anderson Cancer Center), Margaret Morgan(The University of Texas MD Anderson Cancer Center), Keith Baggerly(The University of Texas MD Anderson Cancer Center), Katlin N. Wilson(Inova Health System), Kelly M. Rangel(Cincinnati Children's Hospital Medical Center), Christine Rojas(Inova Health System), Kelly A. Conrads, Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Xizeng Mao(The University of Texas MD Anderson Cancer Center), Andrew Dunn(Akoya Biosciences (United States))
Cited by 144
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor
|Nature Nanotechnology|2008|3.6k
The cancer genome
|Nature|2009|3.5k